Showing results (101-110 of 146) with videos related to
Sort By:
Pageof 15
Anti-Cancer Drugs|February 1, 1994
Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group studyD J Wagener, H E Verdonk, L Y Dirix, et al.Bulletin Du Cancer|March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]T Conroy, J Wils, B Paillot, et al.Cancer Treatment Reports|May 1, 1986
Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of CancerD J Wagener, A T van Oosterom, J H Mulder, et al.Anticancer Research|November 1, 1988
Preclinical pharmacokinetics of the antitumor antibiotic deshydroxy-sparsomycin in beagle dogsZ Zylicz, D J Wagener, M Garzotto, et al.Investigational New Drugs|February 1, 1990
Pharmacokinetics of the antitumor antibiotic n-pentyl-sparsomycin in beagle dogsZ Zylicz, D J Wagener, M Garzotto, et al.European Journal of Cancer & Clinical Oncology|March 1, 1983
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's diseaseP H de Mulder, P D Mier, B E de Pauw, et al.Anticancer Research|November 1, 1989
Modulation of the in vitro cytotoxicity of seven anticancer drugs by protein synthesis inhibition using sparsomycinZ Zylicz, H P Hofs, D J Wagener, et al.Pediatric Pulmonology|October 27, 1999
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosisM Rosenfeld, J Emerson, F Accurso, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Antitumour activity and retinotoxicity of ethyldeshydroxy-sparsomycin in miceH P Hofs, D J Wagener, D De Vos, et al.Pageof 15